| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/16/1999 | US5985319 Multi-phase compositions for an initial and delayed release of a vaginal medicament |
| 11/16/1999 | US5985317 Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
| 11/16/1999 | US5985316 Composition and method of enhancing electrotransport agent delivery |
| 11/16/1999 | US5985313 Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients |
| 11/16/1999 | US5985312 Methods and compositions for enhancing the bioadhesive properties of polymers |
| 11/16/1999 | US5985311 Estrogen, a gestagen or androgen, acrylate adhesive and, as resorption promoters, oleic acid and 2-(2-ethoxyethoxy)ethanol. |
| 11/16/1999 | US5985310 Chelating agent and an antimicrobial preservative which is boric acid and a compound selected from benzalkonium halide compounds, polymeric quaternary ammonium compounds, and quatemary ammonium alkylene glycol phospholipid derivatives |
| 11/16/1999 | US5985309 Preparation of particles for inhalation |
| 11/16/1999 | US5985305 Sustained delivery of an active agent using an implantable system |
| 11/16/1999 | US5985300 Pore cleansing |
| 11/16/1999 | US5985284 To protect against mucosal infection with shigella. |
| 11/16/1999 | US5985259 Sustained release ophthalmic antibiotic compositions |
| 11/16/1999 | US5985255 Fluid composition containing a wax microdispersion and a cationic surfactant, a method for its preparation and uses thereof |
| 11/16/1999 | US5985249 Sticky dental compositions for adhering a passive-type dental tray over a person's teeth |
| 11/16/1999 | US5985248 Preparing dry powders having hydrophobic and hydrophilic components |
| 11/16/1999 | US5985246 Contrast agents for ultrasonic imaging and methods for preparing the same |
| 11/16/1999 | US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis, |
| 11/16/1999 | US5985177 O/W/O type multiple emulsion and method of preparing the same |
| 11/16/1999 | US5983956 Formulation for inhalation |
| 11/16/1999 | CA2142848C Beads having a core coated with an antifungal and a polymer |
| 11/16/1999 | CA1340820C Absorbant precipitated silica and composition containing said silica |
| 11/15/1999 | CA2272042A1 Pharmaceutical formulations of sildenafil |
| 11/14/1999 | CA2271582A1 Method for administration of therapeutic agents, including antisense, with repeat dosing |
| 11/13/1999 | CA2271267A1 Overexpressing human methenyltetrahydrofolate synthetase to sensitize cancer cells to 5-fluorouracil cytotoxicity |
| 11/11/1999 | WO1999057320A1 Antisense modulation of cd40 expression |
| 11/11/1999 | WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications |
| 11/11/1999 | WO1999057094A2 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 11/11/1999 | WO1999056782A1 Adhesive microsphere drug delivery composition |
| 11/11/1999 | WO1999056776A2 Adjuvant composition and methods for its use |
| 11/11/1999 | WO1999056770A2 Novel therapy for treatment of lysosomal storage disease |
| 11/11/1999 | WO1999056766A2 Method for treating ischemia |
| 11/11/1999 | WO1999056757A1 Iodophor compositions for preventing mastitis |
| 11/11/1999 | WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | WO1999056751A1 Aqueous process for manufacturing paroxetine solid dispersions |
| 11/11/1999 | WO1999056743A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 11/11/1999 | WO1999056741A1 Methods for treating female sexual dysfunction |
| 11/11/1999 | WO1999056739A1 A method for chemoprevention of prostate cancer |
| 11/11/1999 | WO1999056737A1 Arylhydrocarbon receptor ligand antagonists |
| 11/11/1999 | WO1999056734A2 Transdermal therapeutic system for the administration of candesartan |
| 11/11/1999 | WO1999056733A1 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation |
| 11/11/1999 | WO1999056732A1 Sugar coated tablets |
| 11/11/1999 | WO1999056731A1 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 11/11/1999 | WO1999056730A1 Method of fabricating a banded prolonged release active agent dosage form |
| 11/11/1999 | WO1999056729A1 Cholesterol lowering composition |
| 11/11/1999 | WO1999056728A1 Pge-1 containing lyopholized liposomes for use in the treatment of erectile dysfunction |
| 11/11/1999 | WO1999056727A2 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| 11/11/1999 | WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 11/11/1999 | WO1999056725A1 Pharmaceutical compositions capable of being gelled |
| 11/11/1999 | WO1999056724A2 Therapeutic system for applying at least one care or active agent topically or transmucosally, on or through the nasal mucosa, and method for using the system |
| 11/11/1999 | WO1999056663A2 Stent with smooth ends |
| 11/11/1999 | WO1999047172A3 Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes |
| 11/11/1999 | WO1999044583A3 Methods and devices for modulating the immune response |
| 11/11/1999 | WO1999044582A3 Nontoxic vernix compositions and method of producing |
| 11/11/1999 | WO1999040031A3 Water purification apparatus |
| 11/11/1999 | WO1999034919B1 Device for coating granules to be administered orally |
| 11/11/1999 | DE4244930C2 High bio:availability cyclosporin compsn. for oral admin. |
| 11/11/1999 | DE19820529A1 Oral or mucosal preparation with controlled release of active agents by coated particles |
| 11/11/1999 | DE19820151A1 Transdermales therapeutisches System zur Anwendung von Candesartan Transdermal therapeutic system for application of candesartan |
| 11/11/1999 | DE19819652A1 Therapeutisches System zur topischen oder transmucosalen Applikation wenigstens eines Pflege- oder Wirkstoffs auf bzw. durch die Nasenschleimhaut sowie Verfahren zur Applikation des Systems Therapeutic system for topical or transmucosal administration of at least one care or substance on or through the nasal mucosa and processes for the application of the system |
| 11/11/1999 | DE19819273A1 Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung Ciclosporin pharmaceutical formulation with improved biopharmaceutical properties, increased physical stability and quality as well as process for preparing |
| 11/11/1999 | DE19818955A1 Zusammensetzung, enthaltend Polyacrylat, Polyterpen, Nitroglycerin und wahlweise Polyvinylacetat Composition containing polyacrylate, polyterpene, nitroglycerin, and optionally, polyvinyl acetate |
| 11/11/1999 | CA2331640A1 Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| 11/11/1999 | CA2331364A1 Arylhydrocarbon receptor ligand antagonists |
| 11/11/1999 | CA2330863A1 Adhesive microsphere drug delivery composition |
| 11/11/1999 | CA2330610A1 Adjuvant composition and methods for its use |
| 11/11/1999 | CA2329866A1 Iodophor compositions for preventing mastitis |
| 11/11/1999 | CA2329736A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 11/11/1999 | CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | CA2325387A1 Method for treating ischemia |
| 11/11/1999 | CA2295323A1 Heparanase specific molecular probes and their use in research and medical applications |
| 11/11/1999 | CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments |
| 11/10/1999 | EP0955359A1 Method for introducing genetic material into a cell |
| 11/10/1999 | EP0955063A1 Use of aqueous compositions in medicaments for subcutaneous or intramuscular administration |
| 11/10/1999 | EP0955062A1 Human growth hormone aqueous formulation |
| 11/10/1999 | EP0955058A1 Lactoferrin tablets |
| 11/10/1999 | EP0955053A1 A plantago major and hypericum perforatum compound for use in treating a tobacco or nicotine habit |
| 11/10/1999 | EP0955048A1 Making dosage units using low shear granulation |
| 11/10/1999 | EP0955043A2 Anti-cellulite pantyhose |
| 11/10/1999 | EP0955042A1 Pharmaceutical composition of estrogen and progesteron |
| 11/10/1999 | EP0955041A2 Aqueous dispersion useful for the production of coating and binding means for oral solid medicament |
| 11/10/1999 | EP0955040A1 Oral composition comprising mesna |
| 11/10/1999 | EP0954573A1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 11/10/1999 | EP0954566A1 Nonoxynol-containing lipid vesicles with anti-viral and spermacidal activity |
| 11/10/1999 | EP0954440A1 Removable protective film for plaster systems, in particular self-adhesive plaster systems, containing active substances |
| 11/10/1999 | EP0954339A2 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules |
| 11/10/1999 | EP0954338A2 Cationic amphiphile/dna complexes |
| 11/10/1999 | EP0954337A1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
| 11/10/1999 | EP0954336A2 Membrane incorporation of texaphyrins |
| 11/10/1999 | EP0954327A1 Useful formulations of acid addition salt drugs |
| 11/10/1999 | EP0954315A2 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
| 11/10/1999 | EP0954314A1 Dosage forms and method for ameliorating male erectile dysfunction |
| 11/10/1999 | EP0954310A1 Synergistic composition comprising rapamycin and calcitriol |
| 11/10/1999 | EP0954309A1 Hiv and cancer treatment |
| 11/10/1999 | EP0954301A1 Methods for providing safe local anesthesia |
| 11/10/1999 | EP0954300A2 Prophylactic and therapeutic treatment of skin sensitization and irritation |
| 11/10/1999 | EP0954294A1 Use of h2-antagonists for the manufacture of a topical composition for the treatment of colds |
| 11/10/1999 | EP0954293A1 Time-specific controlled release dosage formulations and method of preparing same |
| 11/10/1999 | EP0954292A1 Pharmaceutical formulations with delayed drug release |
| 11/10/1999 | EP0954291A1 Soluble form osmotic dose delivery system |
| 11/10/1999 | EP0954290A1 Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose |